A Multiple Ascending-Dose Study of RG7625 in Healthy Volunteers

Inclusion Criteria: * Healthy adult males and females 18 to 60 years of age, inclusive * Body mass index 18.0 to 30.0 kilograms per meter-squared (kg/m\^2), inclusive Exclusion Criteria: * Any clinically relevant abnormalities, concomitant diseases or ongoing medical conditions, abnormal laboratory test results, or a history of any other clinically significant disorders * Any major illness within the one month preceding the Screening visit, or any febrile illness within the two weeks preceding the Screening visit * Any significant allergic reaction to drugs * Immunocompromised or with reduced immune function and/or immunization within 30 days before the first study drug administration or planning vaccination during the study * Women who are pregnant or lactating or of childbearing potential * Clinically significant abnormal electrocardiogram (ECG) or other risk factors for QT prolongation * Use of prescribed or over-the-counter medication * Inability or unwillingness to comply with study requirements